Reduce HRSA compliance issues that occur
during retrospective 340B claim classification.

Identify and Code 340B claims in real-time.

Compliance

Flexible system capabilities for quick adaptability.

Adaptability

SCL 340B CARE maintains industry-leading technology.

Reliability

SCL 340B CARE is the acknowledged leader in
340B program administration.

Experience

340B Administration Challenges

Complete 340B Solution

In response to 340B administrative challenges, we developed SCL 340B CARE. With it, we are able to offer a complete solution that addresses every aspect of program administration and reduces the burdens associated with 340B.  The unique design of our solution allows clients to implement either a turn-key solution or a la carte services to compliment their existing program.

Real-Time Identification and Coding

Our capabilities extend to the real-time identification and coding of 340B claim. This reduces the HRSA compliance issues that occur during retrospective claim classification.

Real-time Processing

SCL 340B CARE offers the industry’s first real-time 340B adjudication platform. We administer 340B management and network development nationwide for Not-for-Profit, DSH, Federally Qualified Health Centers (FQHC) and other 340B qualified entities. Our technology and administration provides eligible entities the ability to provide more patients access to lower drug costs while reducing administrative costs.

340B CARE Blog

  • Thirty years of claims processing experience makes SCL 340B CARE the ideal partner, providing an elite set of services for clients throughout the country. We are the leader in 340B program administration and continually build on this reputation through the constant expansion and excellence of......

  • Prescription drug prices continue to rise and have become one the most important healthcare issues facing the nation. In an effort to address the problem, President Trump announced his drug pricing plan on May 11. After his remarks, analysts are concerned that it could significantly......

  • In 2015, the 340B Drug Discount Program saved healthcare providers $6 billion on drug acquisition costs. While the program aims to make pharmaceutical and clinical care affordable and accessible to low-income patients; there is evidence that some┬áparticipating entities are exploiting its discounts for profit. Since......